{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:05:51Z","timestamp":1782248751497,"version":"3.54.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T00:00:00Z","timestamp":1399334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11060-014-1462-x","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T05:21:12Z","timestamp":1399267272000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage"],"prefix":"10.1007","volume":"119","author":[{"given":"\u00darsula","family":"Urias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely K. N.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseli","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e1 M.","family":"Evagelinellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavia L.","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Wilson A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sueli M.","family":"Oba-Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"key":"1462_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cell.2012.03.009","volume":"149","author":"J Chen","year":"2012","unstructured":"Chen J, McKay RM, Parada LF (2012) Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149:36\u201347","journal-title":"Cell"},{"key":"1462_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"2","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2:97\u2013109","journal-title":"Acta Neuropathol"},{"key":"1462_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00109-004-0564-x","volume":"82","author":"G Reifenberger","year":"2004","unstructured":"Reifenberger G, Collins VP (2004) Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656\u2013670","journal-title":"J Mol Med"},{"key":"1462_CR4","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","volume":"170","author":"H Ohgaki","year":"2007","unstructured":"Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445\u20131453","journal-title":"Am J Pathol"},{"key":"1462_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s10014-011-0029-1","volume":"28","author":"H Ohgaki","year":"2011","unstructured":"Ohgaki H, Kleihues P (2011) Genetic profile of astrocytic and oligodendroglial gliomas. Brain Tumor Pathol 28:177\u2013183","journal-title":"Brain Tumor Pathol"},{"key":"1462_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/03009734.2012.676574","volume":"117","author":"B Westermark","year":"2012","unstructured":"Westermark B (2012) Glioblastoma\u2014a moving target. Upsala J Med Sci 117:251\u2013256","journal-title":"Upsala J Med Sci"},{"key":"1462_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-7827-2-15","volume":"2","author":"R Soundararajan","year":"2004","unstructured":"Soundararajan R, Rao AJ (2004) Trophoblast \u2018pseudo-tumorigenesis\u2019: significance and contributory factors. Reprod Biol Endocrinol 2:15","journal-title":"Reprod Biol Endocrinol"},{"key":"1462_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbaexp.2007.05.002","volume":"1769","author":"OK Okamoto","year":"2007","unstructured":"Okamoto OK, Oba-Shinjo SM, Lopes L, Nagahashi SK (2007) Expression of HOXC9 and E2F2 are up-regulated in CD133 (+) cells isolated from human astrocytomas and associate with transformation of human astrocytes. Biochim Biophys Acta 1769:437\u2013442","journal-title":"Biochim Biophys Acta"},{"key":"1462_CR9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ijc.23189","volume":"122","author":"SK Marie","year":"2008","unstructured":"Marie SK, Okamoto OK, Uno M, Hasegawa AP, Oba-Shinjo SM, Cohen T, Camargo AA, Kosoy A, Carlotti CG Jr, Toledo S, Moreira-Filho CA, Zago MA, Simpson AJ, Caballero OL (2008) Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer 122:807\u2013815","journal-title":"Int J Cancer"},{"key":"1462_CR10","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1101\/gr.4041005","volume":"15","author":"CV Jongeneel","year":"2005","unstructured":"Jongeneel CV, Delorenzi M, Iseli C, Zhou D, Haudenschild CD, Khrebtukova I, Kuznetsov D, Stevenson BJ, Strausberg RL, Simpson AJ, Vasicek TJ (2005) An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res 15:1007\u20131014","journal-title":"Genome Res"},{"key":"1462_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"1462_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1006198422718","volume":"10","author":"M Nomura","year":"1998","unstructured":"Nomura M, Yamagishi S, Harada S, Yamashima T, Yamashima J, Yamamoto H (1998) Placenta Growth Factor (PIGF) mRNA expression in brain tumors. J Neurooncol 10:123\u2013130","journal-title":"J Neurooncol"},{"key":"1462_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/humupd\/dml048","volume":"13","author":"C Ferreti","year":"2007","unstructured":"Ferreti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D (2007) Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update 13:121\u2013141","journal-title":"Hum Reprod Update"},{"key":"1462_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S0025-6196(11)60669-1","volume":"84","author":"SG Holtan","year":"2009","unstructured":"Holtan SG, Creedon DJ, Haluska P, Markovic SN (2009) Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents. Mayo Clin Proc 84:985\u20131000","journal-title":"Mayo Clin Proc"},{"key":"1462_CR15","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1091\/mbc.E05-10-0971","volume":"17","author":"MC Manara","year":"2006","unstructured":"Manara MC, Bernard G, Lollini PL, Nanni P, Zuntini M, Landuzzi L, Benini S, Lattanzi G, Sciandra M, Serra M, Colombo MP, Bernard A, Picci P, Scotlandi K (2006) CD99 acts as an oncosuppressor in osteosarcoma. Mol Biol Cell 17:1910\u20131921","journal-title":"Mol Biol Cell"},{"key":"1462_CR16","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1073\/pnas.76.12.6552","volume":"76","author":"R Levy","year":"1979","unstructured":"Levy R, Dilley J, Fox RI, Warnke R (1979) A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci USA 76:6552\u20136556","journal-title":"Proc Natl Acad Sci USA"},{"key":"1462_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/302346a0","volume":"302","author":"P Goodfellow","year":"1983","unstructured":"Goodfellow P, Banting G, Sheer D, Ropers HH, Caine A, Ferguson-Smith MA, Povey S, Voss R (1983) Genetic evidence that a Y-linked gene in man is homologous to a gene on the X chromosome. Nature 302:346","journal-title":"Nature"},{"key":"1462_CR18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/j.1460-2075.1988.tb03081.x","volume":"7","author":"C Petit","year":"1988","unstructured":"Petit C, Levilliers J, Weissenbach J (1988) Physical mapping of the human pseudoautosomal region; comparison with genetic linkage map. EMBO J 7:2369\u20132376","journal-title":"EMBO J"},{"key":"1462_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0161-5890(89)90100-4","volume":"26","author":"GS Banting","year":"1989","unstructured":"Banting GS, Pym B, Darling SM, Goodfellow PN (1989) The MIC2 gene product: epitope mapping and structural prediction analysis define an integral membrane protein. Mol Immunol 26:181\u2013188","journal-title":"Mol Immunol"},{"key":"1462_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/hyb.2007.0504","volume":"26","author":"P Khunkaewla","year":"2007","unstructured":"Khunkaewla P, Chiampanichayakul S, Yasamut U, Pata S, Kasinrerk W (2007) Production, characterization, and functional analysis of newly established CD99 monoclonal antibodies MT99\/1 and MT99\/2. Hybridoma 26:241\u2013250","journal-title":"Hybridoma"},{"key":"1462_CR21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/j.1462-5822.2008.01143.x","volume":"10","author":"CK Moreira","year":"2008","unstructured":"Moreira CK, Templeton TJ, Lavazec C, Hayward RE, Hobbs CV, Kroeze H, Janse CJ, Waters AP, Sinnis P, Coppi A (2008) The Plasmodium TRAP\/MIC2 family member, TRAP-Like Protein (TLP), is involved in tissue traversal by sporozoites. Cell Microbiol 10:1505\u20131516","journal-title":"Cell Microbiol"},{"key":"1462_CR22","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.4049\/jimmunol.159.5.2250","volume":"159","author":"JH Hahn","year":"1997","unstructured":"Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI, Chung DH, Kim TJ, Lee WJ, Park CK, Ree HJ, Park SH (1997) CD99 (MIC2) regulates the LFA-1\/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol 159:2250\u20132258","journal-title":"J Immunol"},{"key":"1462_CR23","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U","volume":"67","author":"IM Ambros","year":"1991","unstructured":"Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M (1991) MIC2 is a specific marker for Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67:1886\u20131893","journal-title":"Cancer"},{"key":"1462_CR24","first-page":"769","volume":"11","author":"MD Gordon","year":"1998","unstructured":"Gordon MD, Corless C, Renshaw AA, Beckstead J (1998) CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis. Modern Pathol 11:769\u2013773","journal-title":"Modern Pathol"},{"key":"1462_CR25","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M","volume":"30","author":"G Bernard","year":"2000","unstructured":"Bernard G, Raimondi V, Alberti I, Pourtein M, Widjenes J, Ticchioni M, Bernard A (2000) CD99 (E2) up-regulates alpha-4beta1-dependent T cell adhesion to inflamed vascular endothelium under flow conditions. Eur J Immunol 30:3061\u20133065","journal-title":"Eur J Immunol"},{"key":"1462_CR26","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.4049\/jimmunol.178.2.1136","volume":"178","author":"O Lou","year":"2007","unstructured":"Lou O, Alcaide P, Luscinskas FW, Muller WA (2007) CD99 is a key mediator of the transendothelial migration of neutrophils. J Immunol 178:1136\u20131143","journal-title":"J Immunol"},{"key":"1462_CR27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1756-0500-4-293","volume":"4","author":"S Pata","year":"2011","unstructured":"Pata S, Ot\u00e1hal P, Brdi\u010dka T, Laopajon W, Mahasongkram K, Kasinrerk W (2011) Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses. BMC Res Notes 4:293","journal-title":"BMC Res Notes"},{"key":"1462_CR28","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/jid.2011.420","volume":"132","author":"M Torzicky","year":"2012","unstructured":"Torzicky M, Viznerova P, Richter S, Strobl H, Scheinecker C, Foedinger D, Riedl E (2012) Platelet endothelial cell adhesion molecule-1 (PECAM-1\/CD31) and CD99 are critical in lymphatic transmigration of human dendritic cells. J Invest Dermatol 132:1149\u20131157","journal-title":"J Invest Dermatol"},{"key":"1462_CR29","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.02-0049fje","volume":"16","author":"I Alberti","year":"2002","unstructured":"Alberti I, Bernard G, Rouquette-Jazdanian AK, Pelassy C, Pourtein M, Aussel C, Bernard A (2002) CD99 isoforms expression dictates T cell functional outcomes. FASEB J 16:1946\u20131948","journal-title":"FASEB J"},{"key":"1462_CR30","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1182\/blood-2009-12-256388","volume":"116","author":"MG Bixel","year":"2010","unstructured":"Bixel MG, Li H, Petri B, Khandoga AG, Khandoga A, Zarbock A, Wolburg-Buchholz K, Wolburg H, Sorokin L, Zeuschner D, Maerz S, Butz S, Krombach F, Vestweber D (2010) CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis. Blood 116:1172\u20131184","journal-title":"Blood"},{"key":"1462_CR31","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1038\/sj.onc.1207741","volume":"23","author":"V Cerisano","year":"2004","unstructured":"Cerisano V, Aalto Y, Perdichizzi S, Bernard G, Manara MC, Benini S, Cenacchi G, Preda P, Lattanzi G, Nagy B, Knuutila S, Colombo MP, Bernard A, Picci P, Scotlandi K (2004) Molecular mechanisms of CD99-induced caspase-independent cell death and cell\u2013cell adhesion in Ewing\u2019s sarcoma cells: actin and zyxin as key intracellular mediators. Oncogene 23:5664\u20135674","journal-title":"Oncogene"},{"key":"1462_CR32","first-page":"151","volume":"3","author":"D Vestweber","year":"2007","unstructured":"Vestweber D (2007) Molecular mechanisms that control leukocyte extravasation through endothelial cell contacts. Ernst Schering Found Symp Proc 3:151\u2013167","journal-title":"Ernst Schering Found Symp Proc"},{"key":"1462_CR33","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1309\/AJCPE68HZXCGWTKK","volume":"131","author":"D Buxton","year":"2009","unstructured":"Buxton D, Bacchi CE, Gualco G, Weiss LM, Zuppan CW, Rowsell EH, Huang Q, Wang J (2009) Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases. Am J Clin Pathol 131:574\u2013579","journal-title":"Am J Clin Pathol"},{"key":"1462_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1046\/j.1365-2141.1999.01426.x","volume":"105","author":"MN Dworzak","year":"1999","unstructured":"Dworzak MN, Fritsch G, Fleischer C, Printz D, Fr\u00f6schl G, Buchinger P, Mann G, Gadner H (1999) CD99 (MIC2) expression in paediatric B-lineage leukaemia\/lymphoma reflects maturation-associated patterns of normal B-lymphopoiesis. Br J Haematol 105:690\u2013695","journal-title":"Br J Haematol"},{"key":"1462_CR35","first-page":"167","volume":"5","author":"T Terada","year":"2012","unstructured":"Terada T (2012) TDT (\u2212), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia\/lymphoma. Int J Clin Exp Pathol 5:167\u2013170","journal-title":"Int J Clin Exp Pathol"},{"key":"1462_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1046\/j.1365-2559.2001.01309.x","volume":"39","author":"F Milanezi","year":"2001","unstructured":"Milanezi F, Pereira EM, Ferreira FV, Leit\u00e3o D, Schmitt FC (2001) CD99\/MIC-2 surface protein expression in breast carcinomas. Histopathology 39:578\u2013583","journal-title":"Histopathology"},{"key":"1462_CR37","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.humpath.2008.01.013","volume":"39","author":"YE Fong","year":"2008","unstructured":"Fong YE, L\u00f3pez-Terrada D, Zhai QJ (2008) Primary Ewing sarcoma\/peripheral primitive neuroectodermal tumor of the vulva. Hum Pathol 39:1535\u20131539","journal-title":"Hum Pathol"},{"key":"1462_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/002215540405200504","volume":"52","author":"YL Choi","year":"2004","unstructured":"Choi YL, Xuan YH, Shin YK, Chae SW, Kook MC, Sung RH, Youn SJ, Choi JW, Kim SH (2004) An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem 52:591\u2013601","journal-title":"J Histochem Cytochem"},{"key":"1462_CR39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/PAI.0b013e318032cf72","volume":"16","author":"AD Ramsay","year":"2008","unstructured":"Ramsay AD, Bates AW, Williams S, Sebire NJ (2008) Variable antigen expression in hepatoblastomas. Appl Immunohistochem Mol Morphol 16:140\u2013147","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1462_CR40","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/ijc.27518","volume":"131","author":"K Edlund","year":"2012","unstructured":"Edlund K, Lindskog C, Saito A, Berglund A, Pont\u00e9n F, G\u00f6ransson-Kultima H, Isaksson A, Jirstr\u00f6m K, Planck M, Johansson L, Lambe M, Holmberg L, Nyberg F, Ekman S, Bergqvist M, Landelius P, Lamberg K, Botling J, Ostman A, Micke P (2012) CD99 is a novel prognostic stromal marker in non-small cell lung cancer. Int J Cancer 131:2264\u20132273","journal-title":"Int J Cancer"},{"key":"1462_CR41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5858\/2006-130-153-IOMCAT","volume":"130","author":"LC Kang","year":"2006","unstructured":"Kang LC, Dunphy CH (2006) Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes. Arch Pathol Lab Med 130:153\u2013157","journal-title":"Arch Pathol Lab Med"},{"key":"1462_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2011.04.017","volume":"310","author":"L Li","year":"2011","unstructured":"Li L, Li J, Hao C, Zhang C, Mu K, Wang Y, Zhang T (2011) Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique. Cancer Lett 310:9\u201314","journal-title":"Cancer Lett"},{"key":"1462_CR43","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/PAS.0b013e318219c036","volume":"35","author":"Y Guo","year":"2011","unstructured":"Guo Y, Yuan F, Deng H, Wang HF, Jin XL, Xiao JC (2011) Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas. Am J Surg Pathol 35:799\u2013806","journal-title":"Am J Surg Pathol"},{"key":"1462_CR44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5858\/2000-124-0563-IOISIA","volume":"124","author":"YL Choi","year":"2000","unstructured":"Choi YL, Kim HS, Ahn G (2000) Immunoexpression of inhibin \u03b1 subunit, inhibin\/activin \u03b2A subunit and CD99 in ovarian tumors. Arch Pathol Lab Med 124:563\u2013569","journal-title":"Arch Pathol Lab Med"},{"key":"1462_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cup.12049","volume":"40","author":"A Rajagopalan","year":"2013","unstructured":"Rajagopalan A, Browning D, Salama S (2013) CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern. J Cutan Pathol 40:19\u201324","journal-title":"J Cutan Pathol"},{"key":"1462_CR46","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1053\/hupa.2000.16237","volume":"31","author":"F Kommoss","year":"2000","unstructured":"Kommoss F, Oliva E, Bittinger F, Kirkpatrick CJ, Amin MB, Bhan AK, Young RH, Scully RE (2000) Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome. Hum Pathol 31:1055\u20131061","journal-title":"Hum Pathol"},{"key":"1462_CR47","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/00000478-200209000-00008","volume":"26","author":"AL Folpe","year":"2002","unstructured":"Folpe AL, McKenney JK, Bridge JA, Weiss SW (2002) Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol 26:1175\u20131183","journal-title":"Am J Surg Pathol"},{"key":"1462_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/PAS.0b013e318093e421","volume":"32","author":"ED Euscher","year":"2008","unstructured":"Euscher ED, Deavers MT, Lopez-Terrada D, Lazar AJ, Silva EG, Malpica A (2008) Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol 32:219\u2013228","journal-title":"Am J Surg Pathol"},{"key":"1462_CR49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3346\/jkms.2002.17.4.483","volume":"17","author":"KC Jung","year":"2002","unstructured":"Jung KC, Park WS, Bae YM, Hahn JH, Hahn K, Lee H, Lee HW, Koo HJ, Shin HJ, Shin HS, Park YE, Park SH (2002) Immunoreactivity of CD99 in stomach cancer. J Korean Med Sci 17:483\u2013489","journal-title":"J Korean Med Sci"},{"key":"1462_CR50","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1158\/1078-0432.CCR-06-1785","volume":"13","author":"JH Lee","year":"2007","unstructured":"Lee JH, Kim SH, Wang LH, Choi YL, Kim YC, Kim JH, Park TS, Hong YC, Shin YK (2007) Clinical significance of CD99 downregulation in gastric adenocarcinoma. Clin Cancer Res 13:2584\u20132591","journal-title":"Clin Cancer Res"},{"key":"1462_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00022744-200106000-00004","volume":"9","author":"YL Choi","year":"2001","unstructured":"Choi YL, Chi JG, Suh YL (2001) CD99 immunoreactivity in ependymoma. Appl Immunohistochem Mol Morphol 9:125\u2013129","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"1462_CR52","first-page":"41","volume":"10","author":"S Mahfouz","year":"2008","unstructured":"Mahfouz S, Aziz AA, Gabal SM, El-Sheikh S (2008) Immunohistochemical study of CD99 and EMA expression in ependymomas. Medscape J Med 10:41","journal-title":"Medscape J Med"},{"key":"1462_CR53","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1440-1827.2005.01841.x","volume":"55","author":"K Ishizawa","year":"2005","unstructured":"Ishizawa K, Komori T, Hirose T (2005) Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma. Pathol Int 55:377\u2013385","journal-title":"Pathol Int"},{"key":"1462_CR54","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5414\/NPP27118","volume":"27","author":"K Ishizawa","year":"2008","unstructured":"Ishizawa K, Komori T, Shimada S, Hirose T (2008) Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors. Clin Neuropathol 27:118\u2013128","journal-title":"Clin Neuropathol"},{"key":"1462_CR55","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1177\/1947601912473603","volume":"3","author":"HJ Seol","year":"2012","unstructured":"Seol HJ, Chang JH, Yamamoto J, Romagnuolo R, Suh Y, Weeks A, Agnihotri S, Smith CA, Rutka JT (2012) Overexpression of CD99 increases the migration and invasiveness of human malignant glioma cells. Genes Cancer 3:535\u2013549","journal-title":"Genes Cancer"},{"key":"1462_CR56","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2559.1998.00562.x","volume":"33","author":"SK Machen","year":"1998","unstructured":"Machen SK, Fisher C, Gautam RS, Tubbs RR, Goldblum JR (1998) Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumour. Histopathology 33:501\u2013507","journal-title":"Histopathology"},{"key":"1462_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3346\/jkms.2005.20.1.50","volume":"20","author":"SH Yoo","year":"2005","unstructured":"Yoo SH, Han J, Kim TJ, Chung DH (2005) Expression of CD99 in pleomorphic carcinomas of the lung. J Korean Med Sci 20:50\u201355","journal-title":"J Korean Med Sci"},{"key":"1462_CR58","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/modpathol.3800795","volume":"20","author":"PH Hartel","year":"2007","unstructured":"Hartel PH, Fanburg-Smith JC, Frazier AA, Galvin JR, Lichy JH, Shilo K, Franks TJ (2007) Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Modern Pathol 20:760\u2013769","journal-title":"Modern Pathol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-014-1462-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1462-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T16:54:24Z","timestamp":1689180864000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-014-1462-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1462"],"URL":"https:\/\/doi.org\/10.1007\/s11060-014-1462-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,6]]},"assertion":[{"value":"14 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}